Outcomes of unibody endoprosthesis for treatment of aortic aneurysmal pathology and aortoiliac occlusive disease
Published online on July 28, 2025
Abstract
Vascular, Volume 34, Issue 2, Page 330-341, April 2026.
ObjectiveUnibody Endoprosthesis (UBE) is a newer treatment modality for abdominal aortic pathology (AAP) and has increasingly been utilized for aortoiliac occlusive disease (AIOD). We report outcomes of patients undergoing UBE for AAP and AIOD.Methods...
ObjectiveUnibody Endoprosthesis (UBE) is a newer treatment modality for abdominal aortic pathology (AAP) and has increasingly been utilized for aortoiliac occlusive disease (AIOD). We report outcomes of patients undergoing UBE for AAP and AIOD.Methods...